Pluribus Labs’s Lear LEA Stock Holding History

Pluribus Labs’s Portfolio LEA Stock Details LEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,779	Closed	-$508K	–	153
2021 Q4	$508K	Buy	+2,779	New	+$488K	0.54%	49

Other funds holding LEA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pluribus Labs's LEA Position: Q1 2022 in Review

Pluribus Labs sold out of Lear (LEA) in Q1 2022, closing a stake of 2,779 shares — an estimated $508K sold.

Pluribus Labs first reported a position in LEA in Q4 2021 and held it in 1 quarter. The position peaked at $508K in Q4 2021. 410 funds tracked by Wall St. Rank hold LEA as of Q1 2022.

Pluribus Labs reported no remaining Lear position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,779 Lear shares in Q1 2022, an estimated $508K.
Pluribus Labs first reported a position in Lear in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Lear position peaked at $508K in Q4 2021.
410 funds tracked by Wall St. Rank held Lear as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.